![](/img/cover-not-exists.png)
Ibrutinib, idelalisib and obinutuzumab for the treatment of patients with chronic lymphocytic leukemia: three new arrows aiming at the target
Morabito, Fortunato, Gentile, Massimo, Seymour, John F., Polliack, AaronLanguage:
english
Journal:
Leukemia & Lymphoma
DOI:
10.3109/10428194.2015.1061193
Date:
July, 2015
File:
PDF, 2.97 MB
english, 2015